Literature DB >> 10200515

Cisplatin effects on F-actin and matrix proteins precede renal tubular cell detachment and apoptosis in vitro.

M Kruidering1, B van de Water, Y Zhan, J J Baelde, E Heer, G J Mulder, J L Stevens, J F Nagelkerke.   

Abstract

In primary cultures of porcine proximal tubular kidney cells and LLC-PK1 cells cisplatin (5 - 50 microM) caused apoptosis and cell detachment; in both systems cell detachment occurred, preceded by a loss of cytoskeletal F-actin stress fibers within 4 - 6 h, and a reduction of mRNA encoding for fibronectin, collagen a2 type (IV) and laminin B2 within 17 - 41 h. Prevention of F-actin damage by phalloidin prevented nuclear fragmentation, suggesting a relation between F-actin damage and apoptosis. Overexpression of Bcl-2 also prevented apoptosis, but did not prevent damage to the F-actin skeleton or the reduction of mRNA expression of the matrix proteins. These results suggest that Bcl-2 overexpression interferes with apoptotic signals downstream of F-actin. The relevance of these results for cell detachment in kidney toxicity is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10200515     DOI: 10.1038/sj.cdd.4400392

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  26 in total

1.  Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells.

Authors:  Jyotsnabaran Halder; Charles N Landen; Susan K Lutgendorf; Yang Li; Nicholas B Jennings; Dominic Fan; Gina M Nelkin; Rosemarie Schmandt; Michael D Schaller; Anil K Sood
Journal:  Clin Cancer Res       Date:  2005-12-15       Impact factor: 12.531

2.  Fascin2 regulates cisplatin-induced apoptosis in NRK-52E cells.

Authors:  Xinhui Wang; LaNita Nichols; Elizabeth A Grunz-Borgmann; Zhe Sun; Gerald A Meininger; Timothy L Domeier; Christopher P Baines; Alan R Parrish
Journal:  Toxicol Lett       Date:  2016-12-15       Impact factor: 4.372

3.  Cell-matrix adhesions differentially regulate fascin phosphorylation.

Authors:  J C Adams; J D Clelland; G D Collett; F Matsumura; S Yamashiro; L Zhang
Journal:  Mol Biol Cell       Date:  1999-12       Impact factor: 4.138

4.  cAMP signalling protects proximal tubular epithelial cells from cisplatin-induced apoptosis via activation of Epac.

Authors:  Yu Qin; Geurt Stokman; Kuan Yan; Sreenivasa Ramaiahgari; Fons Verbeek; Marjo de Graauw; Bob van de Water; Leo S Price
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

5.  Hsp27 as a negative regulator of cytochrome C release.

Authors:  Catherine Paul; Florence Manero; Sandrine Gonin; Carole Kretz-Remy; Sophie Virot; André-Patrick Arrigo
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

6.  Role of extracellular matrix renal tubulo-interstitial nephritis antigen (TINag) in cell survival utilizing integrin (alpha)vbeta3/focal adhesion kinase (FAK)/phosphatidylinositol 3-kinase (PI3K)/protein kinase B-serine/threonine kinase (AKT) signaling pathway.

Authors:  Ping Xie; Vinay K Kondeti; Sun Lin; Yoshisuke Haruna; Kirtee Raparia; Yashpal S Kanwar
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

7.  Lysophosphatidic acid prevents renal ischemia-reperfusion injury by inhibition of apoptosis and complement activation.

Authors:  Bart de Vries; Robert A Matthijsen; Annemarie A J H M van Bijnen; Tim G A M Wolfs; Wim A Buurman
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

8.  Cisplatin exposure damages resident stem cells of the mammalian inner ear.

Authors:  Eric L Slattery; Kazuo Oshima; Stefan Heller; Mark E Warchol
Journal:  Dev Dyn       Date:  2014-06-25       Impact factor: 3.780

9.  Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells.

Authors:  Grazyna Nowak
Journal:  J Biol Chem       Date:  2002-09-05       Impact factor: 5.157

10.  Cisplatin nephrotoxicity: molecular mechanisms.

Authors:  Marie H Hanigan; Prasad Devarajan
Journal:  Cancer Ther       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.